Skip to content
OpenCapital
Get started

Doximity DOCS Cash And Cash Equivalents, Amortized Cost, Excluding Accrued Interest, After Allowance For Credit Loss

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-—
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0×0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept docs:CashAndCashEquivalentsAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss.

The official record: Doximity’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Doximity's cash and cash equivalents, amortized cost, excluding accrued interest, after allowance for credit loss?
Doximity (DOCS) reported cash and cash equivalents, amortized cost, excluding accrued interest, after allowance for credit loss of $56.69M in Q4 2025.
How has Doximity's cash and cash equivalents, amortized cost, excluding accrued interest, after allowance for credit loss changed year-over-year?
Doximity's cash and cash equivalents, amortized cost, excluding accrued interest, after allowance for credit loss decreased by 63.1% year-over-year, from $153.69M to $56.69M.